Vremeni ostavalos' ochen' malo i ja reshil uskorit' delo, ustroiv sorevnovanie mezhdu dizajjnerami. Dzhin Bordinat, zavedujushhijj otdelom dizajjna, 27 ijulja sobral v.

Abstract Hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE) is a rare autosomal dominant disease characterized by recurrent life-threatening oedemas and/or abdominal pain and caused by mutations affecting the C1 inhibitor gene, SERPING1. We sought to investigate the spectrum of SERPING1 mutations in Serbia and the possible genotype-phenotype association.

C1-INH-HAE was diagnosed on the basis of clinical and laboratory criteria in 40 patients from 27 families; four were asymptomatic. Mutational analysis of the SERPING1 gene was performed by sequencing and multiplex ligation-dependent probe amplification. Disease-causing mutations in SERPING1 were identified in all patients. In C1-INH-HAE type I, we identified 19 different mutations, including 6 missense mutations, 6 nonsense mutations, 2 small deletions, 1 small insertion, 2 splicing defects and 2 large deletions. Two of the mutations (c.300C>T and c.1184_1185insTA) are reported here for the first time.

All C1-INH-HAE type II patients from three families harboured the same substitution (c.1396C>T). Based on the type of mutation identified in the SERPING1 gene, patients were divided into two groups: group 1 (nonsense, frameshift, large deletions/insertions, splicing defect, and mutations at Arg444) or group 2 (missense, excluding mutations at Arg444). Significant differences were found in the clinical severity score (P = 0.005), prevalence of laryngeal (P = 0.040) and facial (P = 0.013) oedema, and long-term prophylaxis (P = 0.023) between the groups with different types of mutations. Because our population consisted of related subjects, differences in the severity score between mutation groups were further confirmed using the generalized estimating equation (P = 0.038). Our study identified 20 different disease-causing mutations, including two novel mutations, in all C1-INH-HAE patients, highlighting the heterogeneity of mutations in the SERPING1 gene. Furthermore, it appears that mutations with a clear effect on C1-INH function might be responsible for a more severe disease phenotype.

Bern hogart risuem golovu cheloveka pdf. • Research family history relating to the Holocaust and explore the Museum's collections about individual survivors and victims of the Holocaust and Nazi persecution. • Learn about over 1,000 camps and ghettos in Volume I and II of this encyclopedia, which are available as a free PDF download. These additional online resources from the U.S. Holocaust Memorial Museum will help you learn more about the Holocaust and research your family history. • The Holocaust Encyclopedia provides an overview of the Holocaust using text, photographs, maps, artifacts, and personal histories.

9 in 1 card reader cr v10 u29g driver: Menu. Submit Local Listings. 9 in 1 card reader cr v10 u29g driver. CR-V10-U29GA The 9 in 1 Card Reader comes available in USB. Albeit only the slot with a card in it will be accessible. At this time you can drag and drop contents with Explorer.

Introduction Hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE) is a rare autosomal dominant disease characterized by recurrent and potentially life-threatening swelling of the skin and upper respiratory tract and abdominal pain. It has an estimated prevalence of one case per 50,000 persons [–]. This rare disease is caused by mutations affecting the C1 inhibitor (C1-INH) gene, SERPING1. C1-INH-HAE can be further divided into two subtypes. C1-INH-HAE type I results in low levels of C1-INH and accounts for 85% of cases. C1-INH-HAE type II results in normal levels of ineffective C1-INH and accounts for 15% of cases [–]. C1-INH is a serine protease inhibitor, and its main function is preventing inappropriate or excessive activation of the complement system.

In addition to the classical pathway, C1-INH also controls the lectin complement pathway and contact, fibrinolytic and coagulation cascades, thus representing a key regulator of several immune and inflammatory pathways [,]. The SERPING1 gene (OMIM #606860) is located on chromosome 11.q12-q13.1, and it consists of eight exons. The first exon contains 38 bp of noncoding sequence, and the second has a 22 bp-long signal peptide before the first methionine; the seven introns distributed over 17 kb contain 17 repetitive Alu sequences [,]. To date, more than 400 different mutations distributed across the entire SERPING1 gene have been described, ranging from nucleotide substitutions to small insertions and deletions to large deletions and duplications (HAEdb, ) [].

De novo mutations in SERPING1 account for approximately 25% of cases with C1-INH-HAE [,]. The aim of this study was to analyse and report the mutational findings in a cohort of 40 patients and four asymptomatic subjects from 27 Serbian families. This is the first report investigating the molecular causes of C1-INH-HAE in Serbia. Furthermore, due to high SERPING1 gene and C1-INH-HAE clinical variability, we investigated the genotype-phenotype relationship to test the hypothesis that nonsense mutations, frameshift mutations, large deletions/insertions, splicing defects, and mutations at Arg444 might be responsible for a more severe disease phenotype in comparison to missense mutations, with the exception of mutations at Arg444.

Patients The patients were diagnosed and recruited during a 20-year period (1995–2015) at the Clinical Center of Serbia (Clinic of Allergy and Immunology), which serves a population of 4 million inhabitants. The Clinical Center of Serbia is a tertiary medical centre responsible for the management of rare diseases in central, northern and western parts of Serbia. Forty patients with C1-INH-HAE, including 4 asymptomatic subjects, from 27 unrelated Serbian families were recruited for genetic analysis. The diagnosis of C1-INH-HAE was established in the presence of clinical (subcutaneous angioedema, abdominal pain, laryngeal oedema) and laboratory criteria (C1-INH antigenic levels, C1-INH function) and followed up with positive family history, as proposed in the guidelines for the diagnosis of C1-INH-HAE [–]. This study was conducted in accordance with the amended Declaration of Helsinki and was approved by the Ethics Committee of the Clinical Center of Serbia (Protocol number 14/6), and all participants gave their written informed consent.